Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
118.84
101.10
85.82
65.34
63.25
62.57
60.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
118.84
101.10
85.82
65.34
63.25
62.57
60.59
Raw Material Cost
28.28
26.10
25.13
15.32
12.29
10.43
10.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
8.03
7.34
6.91
4.69
3.77
2.04
1.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.38
4.68
2.19
0.71
0.10
0.18
0.01
Selling and Distribution Expenses
63.06
50.38
42.04
34.36
36.07
29.91
30.95
Other Expenses
-1.24
-1.20
-0.91
-0.54
-0.39
-0.22
-0.17
Total Expenditure (Excl Depreciation)
91.34
76.48
67.17
49.68
48.36
40.34
41.25
Operating Profit (PBDIT) excl Other Income
27.5
24.6
18.700000000000003
15.700000000000001
14.9
22.200000000000003
19.3
Other Income
1.41
1.15
0.31
0.19
0.13
0.20
0.21
Operating Profit (PBDIT)
38.62
35.23
28.54
19.43
15.50
22.84
19.94
Interest
4.38
4.68
2.19
0.71
0.10
0.18
0.01
Exceptional Items
1.21
0.63
-1.36
-0.94
-0.76
0.00
0.00
Gross Profit (PBDT)
90.56
75.00
60.69
50.02
50.96
52.15
50.29
Depreciation
9.41
9.30
9.19
3.57
0.49
0.40
0.39
Profit Before Tax
26.04
21.89
15.80
14.21
14.15
22.26
19.54
Tax
6.50
5.50
3.85
3.52
3.51
5.56
4.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.54
16.40
11.95
10.69
10.64
16.71
14.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.54
16.40
11.95
10.69
10.64
16.71
14.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.54
16.40
11.95
10.69
10.64
16.71
14.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
31.96
39.75
31.10
22.20
11.51
95.58
84.37
Earnings per share (EPS)
1.65
1.37
1.0
0.89
0.89
1.39
1.23
Diluted Earnings per share
1.65
1.37
1.0
0.89
0.89
1.39
1.23
Operating Profit Margin (Excl OI)
23.4%
24.52%
22.19%
23.97%
23.53%
35.54%
31.92%
Gross Profit Margin
29.83%
30.85%
29.12%
27.21%
23.14%
36.21%
32.88%
PAT Margin
16.44%
16.22%
13.93%
16.36%
16.82%
26.7%
24.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 17.51% vs 17.83% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 18.90% vs 36.67% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 9.09% vs 20.92% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -6.38% vs 113.64% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of PharmaSGP Holding SE With
Figures in Million
Consolidate Annual Results
Change(EUR)
Change(%)
Net Sales
118.84
69.67
49.17
70.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
118.84
69.67
49.17
70.58%
Raw Material Cost
28.28
54.84
-26.56
-48.43%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
8.03
26.04
-18.01
-69.16%
Power Cost
0
0
0.00
Manufacturing Expenses
4.38
1.11
3.27
294.59%
Selling and Distribution Expenses
63.06
21.31
41.75
195.92%
Other Expenses
-1.24
-1.06
-0.18
-16.98%
Total Expenditure (Excl Depreciation)
91.34
92.65
-1.31
-1.41%
Operating Profit (PBDIT) excl Other Income
27.49
-22.98
50.47
219.63%
Other Income
1.41
3.17
-1.76
-55.52%
Operating Profit (PBDIT)
38.62
-10.00
48.62
486.20%
Interest
4.38
1.11
3.27
294.59%
Exceptional Items
1.21
-108.17
109.38
101.12%
Gross Profit (PBDT)
90.56
14.83
75.73
510.65%
Depreciation
9.41
9.81
-0.40
-4.08%
Profit Before Tax
26.04
-129.08
155.12
120.17%
Tax
6.50
-18.58
25.08
134.98%
Provisions and contingencies
0
0
0.00
Profit After Tax
19.54
-125.67
145.21
115.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.54
-125.67
145.21
115.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.54
-125.67
145.21
115.55%
Equity Capital
0
0
0.00
Face Value
1.00
0.00
0.00
Reserves
31.96
461.84
-429.88
-93.08%
Earnings per share (EPS)
1.65
-7.18
8.83
122.98%
Diluted Earnings per share
1.65
-7.18
8.83
122.98%
Operating Profit Margin (Excl OI)
23.40%
-32.98%
0.00
56.38%
Gross Profit Margin
29.83%
-171.19%
0.00
201.02%
PAT Margin
16.44%
-180.37%
0.00
196.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 11.88 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 17.51% vs 17.83% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 1.95 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 18.90% vs 36.67% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.72 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 9.09% vs 20.92% in Dec 2023
Annual - Interest
Interest 0.44 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -6.38% vs 113.64% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.40%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






